SCHEMBL9513060

SCHEMBL9513060

CC(C=O)n1cc(OC(=O)O)c(=O)c2cc(F)c(F)c(F)c21

nearest known ligand 0.39

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
STAT3 P40763 2/20 0.36
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 1/20 0.34
POLB P06746 1/20 0.34
HSP90AA1 P07900 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
TOP1 P11387 1/20 0.30
KMT2A Q03164 1/20 0.30
TOP2A P11388 2/20 0.30
TOP2B Q02880 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10542756 0.84 KDM4E (0.45) STAT3KDM4EALDH1A1POLBHSP90AA1
SCHEMBL6213206 0.79 KDM4E (0.38) STAT3KDM4EALDH1A1POLBHSP90AA1
SCHEMBL6213036 0.78 STAT3 (0.38) STAT3KDM4EALDH1A1POLBHSP90AA1
SCHEMBL9512927 0.76 STAT3 (0.37) STAT3KDM4EALDH1A1POLBHSP90AA1
SCHEMBL8136263 0.76 TOP2A (0.45) STAT3KDM4EALDH1A1POLBHSP90AA1
SCHEMBL6212721 0.76 STAT3 (0.38) STAT3KDM4EALDH1A1POLBHSP90AA1
SCHEMBL6217745 0.76 KDM4E (0.45) STAT3KDM4EALDH1A1POLBHSP90AA1
SCHEMBL6214790 0.74 KDM4E (0.49) STAT3KDM4EALDH1A1POLBHSP90AA1
SCHEMBL10913630 0.73 ALDH1A1 (0.48) STAT3KDM4EALDH1A1POLBHSP90AA1
SCHEMBL9047184 0.72 ALDH1A1 (0.47) STAT3KDM4EALDH1A1POLBHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0563732-A1 7-oxo-7H-pyrido(1,2,3-de)(1,4)benzoxazinecarboxylic acids and esters and their use as antiviral agents BAYER AG (DE) 1993-10-06 EP disclosed
EP-0563733-A1 Use of 7-oxo-7H-pyrido(1,2,3-de)(1,4)benzoxacin-6-carboxylic acid- and esters for the manufacture of a medicament for the treatment of viral diseases BAYER AG (DE) 1993-10-06 EP disclosed
EP-0253235-B1 1,8-BRIDGED 4-QUINOLONE CARBOXYLIC ACIDS AND MEDICAMENTS CONTANING THEM BAYER AG (DE) 1991-01-02 EP disclosed
EP-0253235-A1 1,8-Bridged 4-quinolone carboxylic acids and medicaments contaning them BAYER AG (DE) 1988-01-20 EP disclosed